Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kids MoD PAH Trial
NCT04039464Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2022
- Primary completion
- Dec 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by Johns Hopkins University. Started Aug 2022; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT04039464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039464.